Quantification of homocysteine-related metabolites and the role of betaine-homocysteine S-methyltransferase in HepG2 cells
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388963%3A_____%2F13%3A00391512" target="_blank" >RIV/61388963:_____/13:00391512 - isvavai.cz</a>
Výsledek na webu
<a href="http://dx.doi.org/10.1002/bmc.2755" target="_blank" >http://dx.doi.org/10.1002/bmc.2755</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1002/bmc.2755" target="_blank" >10.1002/bmc.2755</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Quantification of homocysteine-related metabolites and the role of betaine-homocysteine S-methyltransferase in HepG2 cells
Popis výsledku v původním jazyce
We optimized and validated a rapid and sensitive liquid chromatographytandem mass spectrometry (LC-MS/MS) method for the quantification of six metabolites of homocysteine metabolism: homocysteine, methionine, cysteine, S-adenosylmethionine, S-adenosylhomocysteine and betaine. The detection limits for these metabolites were in the nanomolar range, and the intra- and inter-day precisions were lower than 20% of the relative standard deviations. The method was specifically designed for the determination ofthe intracellular concentrations of the metabolites in cultured cells. To study the role of betainehomocysteine S-methyltransferase (BHMT), HepG2 cells and HepG2 cells that were stably transfected with BHMT (BHMTHepG2) were treated with homocysteine or with a specific inhibitor of BHMT, and metabolite levels were subsequently measured. Severely compromised methyl group metabolism in the HepG2 cells, which is typical of cancer-derived cells, prevented clear evaluation of the changes cause
Název v anglickém jazyce
Quantification of homocysteine-related metabolites and the role of betaine-homocysteine S-methyltransferase in HepG2 cells
Popis výsledku anglicky
We optimized and validated a rapid and sensitive liquid chromatographytandem mass spectrometry (LC-MS/MS) method for the quantification of six metabolites of homocysteine metabolism: homocysteine, methionine, cysteine, S-adenosylmethionine, S-adenosylhomocysteine and betaine. The detection limits for these metabolites were in the nanomolar range, and the intra- and inter-day precisions were lower than 20% of the relative standard deviations. The method was specifically designed for the determination ofthe intracellular concentrations of the metabolites in cultured cells. To study the role of betainehomocysteine S-methyltransferase (BHMT), HepG2 cells and HepG2 cells that were stably transfected with BHMT (BHMTHepG2) were treated with homocysteine or with a specific inhibitor of BHMT, and metabolite levels were subsequently measured. Severely compromised methyl group metabolism in the HepG2 cells, which is typical of cancer-derived cells, prevented clear evaluation of the changes cause
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
CE - Biochemie
OECD FORD obor
—
Návaznosti výsledku
Projekt
<a href="/cs/project/GAP207%2F10%2F1277" target="_blank" >GAP207/10/1277: Nové inhibitory lidských methyltransferáz BHMT a BHMT-2 pro studium jejich fyziologických funkcí</a><br>
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2013
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Biomedical Chromatography
ISSN
0269-3879
e-ISSN
—
Svazek periodika
27
Číslo periodika v rámci svazku
1
Stát vydavatele periodika
GB - Spojené království Velké Británie a Severního Irska
Počet stran výsledku
11
Strana od-do
111-121
Kód UT WoS článku
000312306300015
EID výsledku v databázi Scopus
—